Phase 3 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) trials recruiting now

All Metastatic Hormone-sensitive Prostate Cancer (mHSPC) trials, every phase

Phase 3 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) trials

• A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
  NCT07241416 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 1 location
• Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC
  NCT05956639 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 1 location
• ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer
  NCT03903835 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 32 locations

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.